Salafibrate

This classification denotes an anti-lipidemic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HJ57229JPX. European Medicines Agency schedules Salafibrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10416MIG. Salafibrate generally arises in the molecular formula C32H32CL2O10. The term SALAFIBRATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, no. 10 1979, list 19.) SALAFIBRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule salafibrate under HS 29182200 and SITC 51393. As of Q4 2014, SALAFIBRATE remains the US FDA Preferred Term for this commodity. Salafibrate bears US NLM identifiers UMLS ID C2348131 and NCI Concept Code C72996. SMILES: Clc1ccc(OC(C(=O)OCC(OC(=O)c2c(OC(=O)C)cccc2)COC(=O)C(Oc2ccc(Cl)cc2)(C)C)(C)C)cc1.